Abstract
Background
Few
studies
have
directly
compared
the
risk
and
magnitude
of
post-acute
sequelae
following
COVID-19
influenza,
most
these
were
conducted
before
emergence
Omicron.
This
study
investigated
prevalence
post-COVID
conditions
long-term
emergency
department
(ED)
visits,
hospitalizations,
deaths
in
patients
with
their
that
influenza.
Methods
A
retrospective
based
on
TriNetX
databases,
a
global
health
research
network.
We
identified
influenza
who
required
hospitalization
between
January
1,
2022,
2023.
developing
any
two
groups
also
analyzed
each
post-COVID-19
condition
all-cause
ED
both
populations
during
follow-up
90–180
days.
Results
Before
matching,
7,187
older
(63.9
±
16.7
vs.
55.4
21.2)
predominantly
male
(54.0%
45.4%),
overweight/obese
(16.1%
11.2%)
than
11,266
individuals
After
propensity
score
6,614
group,
resulting
well-balanced
baseline
characteristics.
During
follow-up,
group
had
higher
incidence
when
(17.9%
13.0%),
hazard
ratio
(HR)
1.398
(95%
CI,
1.251–1.562).
Compared
to
significantly
abnormal
breathing
(HR,
1.506;
95%
1.246–1.822),
abdominal
symptoms
1.313;
HR,
1.034–1.664),
fatigue
1.486;
1.158–1.907),
cognitive
1.815;
1.235–2.668).
Moreover,
composite
outcomes
(27.5%
21.7;
1.303;
1.194–1.422).
Conclusions
indicates
hospitalized
are
at
complications
survivors.
Frontiers in Immunology,
Год журнала:
2024,
Номер
15
Опубликована: Март 4, 2024
The
coronavirus
disease
2019
(COVID-19)
pandemic
caused
by
SARS-CoV-2
has
been
defined
as
the
greatest
global
health
and
socioeconomic
crisis
of
modern
times.
While
most
people
recover
after
being
infected
with
virus,
a
significant
proportion
them
continue
to
experience
issues
weeks,
months
even
years
acute
infection
SARS-CoV-2.
This
persistence
clinical
symptoms
in
individuals
for
at
least
three
onset
or
emergence
new
lasting
more
than
two
months,
without
any
other
explanation
alternative
diagnosis
have
named
long
COVID,
long-haul
post-COVID-19
conditions,
chronic
post-acute
sequelae
(PASC).
Long
COVID
characterized
constellation
disorders
that
vary
widely
their
manifestations.
Further,
mechanisms
underlying
are
not
fully
understood,
which
hamper
efficient
treatment
options.
review
describes
predictors
common
related
COVID's
effects
on
central
peripheral
nervous
system
organs
tissues.
Furthermore,
transcriptional
markers,
molecular
signaling
pathways
risk
factors
such
sex,
age,
pre-existing
condition,
hospitalization
during
phase
COVID-19,
vaccination,
lifestyle
presented.
Finally,
recommendations
patient
rehabilitation
management,
well
therapeutical
approaches
discussed.
Understanding
complexity
this
disease,
its
across
multiple
organ
systems
overlapping
pathologies
possible
paramount
developing
diagnostic
tools
treatments.
International Journal for Equity in Health,
Год журнала:
2023,
Номер
22(1)
Опубликована: Дек. 13, 2023
Long
COVID
symptoms
-
which
include
brain
fog,
depression,
and
fatigue
are
mild
at
best
debilitating
worst.
Some
U.S.
health
surveys
have
found
that
women,
lower
income
individuals,
those
with
less
education
overrepresented
among
adults
long
COVID,
but
these
studies
do
not
address
intersectionality.
To
fill
this
gap,
we
conduct
an
intersectional
analysis
of
the
prevalence
outcomes
in
We
posit
disparities
to
virus
itself
more
social
determinants
health,
especially
associated
occupational
segregation
gendered
division
household
work.We
use
10
rounds
Household
Pulse
Survey
(HPS)
data
collected
between
June
2022
March
2023
perform
using
a
battery
descriptive
statistics
evaluate
(1)
(2)
interference
day-to-day
activities.
also
HPS
estimate
set
multivariate
logistic
regressions
relate
odds
having
activity
limitations
due
individual
characteristics
as
well
intersections
by
sex,
race/ethnicity,
education,
sexual
orientation
gender
identity.Findings
indicate
some
people
color,
minorities,
without
college
degrees
likely
from
COVID.
Women
considerably
higher
developing
compared
men,
disparity
exacerbated
education.
Intersectional
gender,
race,
ethnicity,
reveals
striking
step-like
pattern:
college-educated
men
lowest
while
women
educations
highest
prevalence.
Daily
evenly
distributed
across
demographics,
different
pattern
is
present:
fewer
widespread
degrees.
Regression
results
confirm
negative
association
being
woman,
educated,
Hispanic,
minority,
for
effects
nuanced.Results
point
systematic
highlighting
urgent
need
policies
increase
access
quality
healthcare,
strengthen
safety
net,
reduce
economic
precarity.
Microorganisms,
Год журнала:
2023,
Номер
11(12), С. 2959 - 2959
Опубликована: Дек. 11, 2023
The
presence
of
symptoms
after
an
acute
SARS-CoV-2
infection
(long-COVID)
has
become
a
worldwide
healthcare
emergency
but
remains
underestimated
and
undertreated
due
to
lack
recognition
the
condition
knowledge
underlying
mechanisms.
In
fact,
prevalence
post-COVID
ranges
from
50%
during
first
months
up
20%
two-years
after.
This
perspective
review
aimed
map
existing
literature
on
identify
gaps
in
guide
global
effort
toward
improved
understanding
long-COVID
suggest
future
research
directions.
There
is
plethora
symptomatology
that
can
be
COVID-19;
however,
today,
there
no
clear
classification
definition
this
condition,
termed
or
post-COVID-19
condition.
heterogeneity
led
groups/clusters
patients,
which
could
exhibit
different
risk
factors
Viral
persistence,
long-lasting
inflammation,
immune
dysregulation,
autoimmune
reactions,
reactivation
latent
infections,
endothelial
dysfunction
alteration
gut
microbiota
have
been
proposed
as
potential
mechanisms
explaining
complexity
long-COVID.
such
equation,
viral
biology
(e.g.,
re-infections,
variants),
host
genetics,
epigenetics)
external
vaccination)
should
also
considered.
These
various
will
discussed
current
directions
suggested.
Scientific Reports,
Год журнала:
2024,
Номер
14(1)
Опубликована: Апрель 2, 2024
Abstract
This
study
investigated
long
COVID
of
patients
in
the
Montefiore
Health
System
COVID-19
(CORE)
Clinics
Bronx
with
an
emphasis
on
identifying
health
related
social
needs
(HRSNs).
We
analyzed
a
cohort
643
CORE
(6/26/2020–2/24/2023)
and
52,089
non-CORE
patients.
Outcomes
included
symptoms,
physical,
emotional,
cognitive
function
test
scores
obtained
at
least
three
months
post-infection.
Socioeconomic
variables
median
incomes,
insurance
status,
HRSNs.
The
was
older
age
(53.38
±
14.50
vs.
45.91
23.79
years
old,
p
<
0.001),
more
female
(72.47%
56.86%,
had
higher
prevalence
hypertension
(45.88%
23.28%,
diabetes
(22.86%
13.83%,
COPD
(7.15%
2.28%,
asthma
(25.51%
12.66%,
lower
incomes
(53.81%
43.67%,
1
st
quintile,
unmet
(29.81%
18.49%,
0.001)
compared
to
survivors.
reported
wide
range
severe
long-COVID
symptoms.
HRSNs
experienced
worse
ESAS-r
(tiredness,
wellbeing,
shortness
breath,
pain),
PHQ-9
(12.5
(6,
17.75)
7
(2,
12),
GAD-7
(8.5
(3,
15)
4
(0,
9),
without.
Patients
outcomes
those
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(12), С. 6389 - 6389
Опубликована: Июнь 9, 2024
Long
COVID
(LC),
also
referred
to
as
Post
COVID-19
Condition,
Post-Acute
Sequelae
of
SARS-CoV-2
Infection
(PASC),
and
other
terms,
represents
a
complex
multisystem
disease
persisting
after
the
acute
phase
COVID-19.
Characterized
by
myriad
symptoms
across
different
organ
systems,
LC
presents
significant
diagnostic
management
challenges.
Central
disorder
is
role
low-grade
inflammation,
non-classical
inflammatory
response
that
contributes
chronicity
diversity
observed.
This
review
explores
pathophysiological
underpinnings
LC,
emphasizing
importance
inflammation
core
component.
By
delineating
pathogenetic
relationships
clinical
manifestations
this
article
highlights
necessity
for
an
integrated
approach
employs
both
personalized
medicine
standardized
protocols
aimed
at
mitigating
long-term
consequences.
The
insights
gained
not
only
enhance
our
understanding
but
inform
development
therapeutic
strategies
could
be
applicable
chronic
conditions
with
similar
features.
Vaccines,
Год журнала:
2024,
Номер
12(6), С. 566 - 566
Опубликована: Май 22, 2024
The
share
of
the
elderly
population
is
growing
worldwide
as
life
expectancy
increases.
Immunosenescence
and
comorbidities
increase
infectious
diseases’
morbidity
mortality
in
older
adults.
Here,
we
aimed
to
summarize
latest
findings
on
vaccines
for
against
herpes
zoster,
influenza,
respiratory
syncytial
virus
(RSV),
COVID-19,
pneumococcal
disease
examine
vaccine
recommendation
differences
this
age
group
Europe
United
States.
PubMed
was
searched
using
keywords
“elders”
“vaccine”
alongside
disease/pathogen
question
paraphrased
or
synonymous
terms.
Vaccine
recommendations
were
also
sought
European
US
Centers
Disease
Control
Prevention
databases.
Improved
vaccines,
tailored
elderly,
mainly
by
novel
adjuvants
increasing
antigen
concentration,
are
now
available.
Significant
exist
between
immunization
policies,
especially
countries,
terms
recipient’s
age,
number
doses,
vaccination
schedule,
implementation
(mandatory
recommended).
Understanding
factors
that
influence
immune
response
may
help
design
offer
long-term
protection
vulnerable
group.
A
consensus-based
strategy
could
fill
gaps
policy
particularly
regarding
RSV
pneumococcus.
Science Translational Medicine,
Год журнала:
2024,
Номер
16(773)
Опубликована: Ноя. 13, 2024
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV
2)
pandemic
has
caused
more
than
7
million
deaths
globally.
Despite
the
presence
of
infection-
and
vaccine-induced
immunity,
SARS-CoV-2
infections
remain
a
major
global
health
concern
because
emergence
variants
that
can
cause
disease
2019
(COVID-19)
or
enhance
Long
Covid
phenotypes.
About
5
to
10%
SARS-CoV-2-infected
individuals
develop
Covid,
which,
similar
COVID
19,
often
affects
lung.
However,
also
affect
other
peripheral
organs,
especially
brain.
causal
relationships
between
phenotypes,
long-term
symptoms,
involvement
multiple
organ
systems
elusive,
animal
model
mimicking
both
post-acute
phases
are
imperative.
Here,
we
review
current
state
models,
including
possible
future
applications.
Inflammopharmacology,
Год журнала:
2023,
Номер
32(1), С. 249 - 271
Опубликована: Ноя. 13, 2023
Abstract
Nearly
four
years
after
its
first
appearance,
and
having
gone
from
pandemic
to
endemic,
the
SARS-CoV-2
remains
out
of
control
globally.
The
purpose
this
study
was
evaluate
clinical
efficacy
vitamin
D
(VD)
in
COVID-19
long
COVID-19,
explain
discrepancy
outcomes
highlight
potential
impact
metformin
on
VD
recent
articles.
Articles
January
2022
August
2023
were
selected
for
review.
objective
achieved
by
reviewing,
analyzing,
discussing
articles
demonstrating
(1)
mechanism
action
(2)
observational
or
randomized
trials
(RCTs)
that
support
not
beneficial
effects
COVID.
(3)
genetic
non-genetic
reasons
variation
VD.
collected
electronic
databases
such
as
PubMed,
Scopus,
MEDLINE,
Google
Scholar,
Egyptian
Knowledge
Bank,
Science
Direct,
Cochrane
Database
Systematic
Reviews.
Twenty
three
studies
conducted
vitro
animal
models
indicated
may
act
through
protecting
respiratory
system
antimicrobial
peptide
cathelicidins,
reducing
lung
inflammation,
regulating
innate
adaptive
immune
functions
up
regulation
autophagy
gene
activity.
Our
review
identified
58
met
criteria.
number
publications
supporting
a
activity
treating
49
(86%),
including
12
meta-analyses.
Although
total
patients
included
all
14,071,273,
role
14,029,411
(99.7%).
Collectively,
extensive
decisive
relationship
between
low
levels
severity
mortality
outcomes.
Importantly,
evidence
intervention
has
demonstrated
effectiveness
supplements
COVID-19.
Furthermore,
results
4
supported
alleviating
symptoms
disease.
However,
eight
RCTs
one
meta-analysis
contain
low-grade
against
Twenty-five
have
addressed
association
VDR
DBP
polymorphisms
treatment
failure
Impaired
signaling
underlie
variability
mechanisms.
Interestingly,
studies,
therapeutic
possibly
improving
AMPK
enhancing
In
conclusion,
been
significantly
strengthened
over
past
18
months,
with
several
meta-analyses
reporting
conclusive
supplementation
highlighting
improve
sensitivity